Johnson & Johnson Ovarian Cancer Lawsuit: Current Status

What the Lawsuits Allege

The litigation involves tens of thousands of women who allege that long-term use of Johnson & Johnson talc-based powder products, primarily Baby Powder and Shower to Shower, caused them to develop ovarian cancer, with related claims alleging mesothelioma. Plaintiffs allege the talc was contaminated with asbestos and that J&J was aware of contamination risk for decades but did not warn consumers. The federal cases are consolidated as MDL-2738 in the U.S. District Court for the District of New Jersey, with roughly 68,000 cases pending, making it one of the largest active mass torts in the country.

Johnson & Johnson denies that its talc products cause cancer and maintains they do not contain asbestos. The causation question is scientifically contested. An international cancer research body reclassified talc in 2024 in a way plaintiffs cite as supportive, while J&J points to other evidence; the dispute over the science is central to the litigation rather than settled.

The Failed Bankruptcy Settlement

For several years J&J pursued an unusual strategy: routing its talc liability into a subsidiary, most recently called Red River Talc, and using bankruptcy to drive a global settlement. The proposed plan was reported in the range of eight to nine billion dollars to be paid over decades to resolve current and future ovarian cancer claims. In March 2025, a federal bankruptcy judge in Texas rejected the plan, citing problems with how support for it was solicited and counted and with releases it would have granted. J&J said it would not appeal.

The collapse of that plan is the pivotal recent event. It means there is no approved global settlement, and the cases returned to the regular court system rather than being resolved through bankruptcy. Plaintiffs who had hoped for a faster bankruptcy-driven payout instead face continued litigation.

Where the Cases Stand Now

With bankruptcy off the table, the litigation resumed in both federal and state courts. A mediator was appointed in 2025 to oversee settlement discussions, and the first federal bellwether case was selected while state courts in California and elsewhere moved their own ovarian cancer trials forward. Bellwether trials are test cases whose outcomes tend to shape any broader settlement negotiations.

Verdicts in individual talc cases have varied widely, with some very large jury awards that are frequently appealed or reduced, so they are not a reliable predictor of any individual outcome. New claims continue to be filed. Because eligibility, evidence, and deadlines are specific to each person, anyone considering a claim should get an individual assessment rather than rely on headline verdict numbers.

How to Get Legal Help

If you or a family member fits the description here, a consultation with a lawyer who handles this specific litigation is the reliable next step. Deadlines vary and can be unforgiving, most of these firms offer a free review, and these cases are typically taken on contingency, so you pay nothing unless they recover for you.

To follow filings, trial outcomes, and any settlement news, bookmark this page and subscribe to LawsuitWatch alerts.